Login / Signup

Darkness hormone or daylight hormone in women with systemic lupus erythematosus?

Melek BilginAdem KeskinRecai AciHatice Sule BaklaciogluMukadder Arslanbek Erdem
Published in: Clinical rheumatology (2022)
Women with SLE had lower melatonin and 25-hydroxyvitamin D3 levels than healthy women. On the other hand, parameters of laboratory diagnostic criteria of SLE disease were not related. Only 25-hydroxyvitamin D3 levels were inversely related leukocyte levels. SLE disease activity was not correlated with melatonin levels but negatively correlated with 25-hydroxyvitamin D3 levels. Key Points • Women with SLE have low levels of melatonin and 25-hydroxyvitamin D3. • Melatonin and 25-hydroxyvitamin D3 levels are not related to the laboratory diagnostic criteria parameters for SLE disease. • Low levels of melatonin and 25-hydroxyvitamin D3 may be a factor in the unbalanced immune system of SLE. • Supplementation of melatonin and 25-hydroxyvitamin D3 may be recommended for women patients with SLE.
Keyphrases
  • systemic lupus erythematosus
  • disease activity
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • polycystic ovary syndrome
  • insulin resistance